wegovy tirzepatide F.D.A. Approves New Obesity Drug That Will Compete With Diabetes drug tirzepatide linked to

Save on your treatment from IsraelPharm

Use of glucagon-like peptide 1 agonists for weight loss compared with bupropion-naltrexone was associated with an increased risk for pancreatitis, gastroparesis and bowel obstruction but not biliary disease, researchers reported in JAMA

Celebrity weight loss often involves semaglutide, a GLP-1 receptor agonist originally developed for diabetes

Lillys kiboshed trial is a reminder that weight loss drugmakers need to look beyond drug solutions and support patients efforts to maintain muscle mass

Semaglutide Troche + B6 is a convenient, dissolvable treatment designed to support weight management and metabolic health

Patients who combine GLP-1 therapy with CGM monitoring tend to make smarter lifestyle choices and see better outcomes